Predictors of Efficacy Maintenance After Vunakizumab Discontinuation in Patients With Moderate‐to‐Severe Plaque Psoriasis: A Post Hoc Analysis of a Randomized Controlled Trial

Documents similaires

• Efficacy and Safety of Oral Icotrokinra in Moderate‐to‐Severe Plaque Psoriasis: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis
  par: Alhasan Altayf, et autres
  Publié: (2026)
• Comprehensive Literature Review Evaluating the Use, Safety, and Efficacy of Subcutaneous Methotrexate in the Treatment of Adult Patients With Moderate‐To‐Severe Plaque‐Type Psoriasis
  par: Manuelle Viguier, et autres
  Publié: (2025)
• Efficacy of Biologics for the Treatment of Moderate‐To‐Severe Plaque Psoriasis in the Asian Population: A Systematic Review and Network Meta‐Analysis
  par: Akihiko Asahina, et autres
  Publié: (2025)
• Real‐World Experience of Secukinumab Treatment in Patients with Moderate‐to‐Severe Plaque Psoriasis in Greece: 3‐Year Interim Results of the SERENA Study
  par: Dimitrios Ioannides, et autres
  Publié: (2024)
• A Real‐World Study on the Characteristics, Treatment Patterns, and Healthcare Resource Utilization in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Systemic Treatment in China
  par: Beibei Zhu, et autres
  Publié: (2026)